We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus.
- Authors
Christensen, Sean R; Kashgarian, Michael; Alexopoulou, Lena; Flavell, Richard A; Akira, Shizuo; Shlomchik, Mark J
- Abstract
Systemic autoimmune disease in humans and mice is characterized by loss of immunologic tolerance to a restricted set of self-nuclear antigens. Autoantigens, such as double-stranded (ds) DNA and the RNA-containing Smith antigen (Sm), may be selectively targeted in systemic lupus erythematosus because of their ability to activate a putative common receptor. Toll-like receptor 9 (TLR9), a receptor for CpG DNA, has been implicated in the activation of autoreactive B cells in vitro, but its role in promoting autoantibody production and disease in vivo has not been determined. We show that in TLR9-deficient lupus-prone mice, the generation of anti-dsDNA and antichromatin autoantibodies is specifically inhibited. Other autoantibodies, such as anti-Sm, are maintained and even increased in TLR9-deficient mice. In contrast, ablation of TLR3, a receptor for dsRNA, did not inhibit the formation of autoantibodies to either RNA- or DNA-containing antigens. Surprisingly, we found that despite the lack of anti-dsDNA autoantibodies in TLR9-deficient mice, there was no effect on the development of clinical autoimmune disease or nephritis. These results demonstrate a specific requirement for TLR9 in autoantibody formation in vivo and indicate a critical role for innate immune activation in autoimmunity.
- Publication
The Journal of experimental medicine, 2005, Vol 202, Issue 2, p321
- ISSN
0022-1007
- Publication type
Journal Article
- DOI
10.1084/jem.20050338